Anjalee Khemlani

CVS Health is working to balance all parts of its vertically integrated business under new leadership. CEO David Joyner tells Yahoo Finance he's working to define the company.

Eli Lilly CEO says Trump tariff threat has already achieved the goal of repatriating manufacturing in pharma.

Eli Lilly's CEO waved off the Novo Nordisk-CVS GLP-1 formulary deal as he focuses on the future of the company's obesity pipeline.

Humana reported a beat in first quarter earnings Wednesday.

Humana reported a beat in first quarter earnings Wednesday.

Novo Nordisk launched access to its popular weight loss GLP-1 drug, Wegovy, through multiple telehealth platforms, including Hims & Hers.

Healthcare used to be considered a safe, constant growth sector, weighted heavily in some 401(k)s. But it isn't immune to current market volatility.

Vaccines have been a central focus for Trump's health leaders, but large-cap players aren't feeling the sting.

UnitedHealth Group's stock is still under pressure Monday, days after the company revised down its EPS guidance for the year.

UnitedHealth Group's tough first quarter signals trouble for other insurers.